OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins
- 1 May 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 14 (5), 219-227
- https://doi.org/10.1016/j.molmed.2008.03.002
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- FoxO tumor suppressors and BCR–ABL-induced leukemia: A matter of evasion of apoptosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2008
- Erythropoietin involves the phosphatidylinositol 3‐kinase pathway, 14‐3‐3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrityBritish Journal of Pharmacology, 2007
- Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathwaysCellular Signalling, 2007
- FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell HomeostasisCell, 2007
- In control of biology: of mice, men and FoxesBiochemical Journal, 2006
- Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3aProceedings of the National Academy of Sciences, 2006
- A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life SpanCell, 2006
- Transcriptional feedback control of insulin receptor by dFOXO/FOXO1Genes & Development, 2005
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- FOXO Proteins Regulate Tumor Necrosis Factor-related Apoptosis Inducing Ligand ExpressionJournal of Biological Chemistry, 2002